U.S. FDA Triples Estimate On Deaths Following Allergic Reaction To Blood Thinner Heparin
This article was originally published in PharmAsia News
Executive Summary
BEIJING - U.S. FDA last week issued a sharply higher estimate on the number of deaths that have occurred in patients who suffered allergic reactions to the blood thinner heparin